(Reuters) -German medical technology company Siemens Healthineers on Wednesday reported third-quarter revenue slightly above analysts’ consensus, citing strong growth in its China business after declines last year.
The company’s revenue was 5.66 billion euros ($6.54 billion) in the quarter, compared to the 5.61 billion expected by analysts in a poll compiled by Vara Research and up 7.6% from last year on a comparable basis.
Siemens Healthineers also slightly raised its full year outlook, citing the framework trade agreement the European Union and the U.S. reached on Sunday.
The company expects comparable revenue growth between 5.5% and 6% in 2025, after previously guiding for 5-6%, and adjusted basic earnings of 2.30-2.45 euros per share, from 2.20-2.50 euros expected in May.
“We had a very good quarter with high revenue growth, another increase in profitability and strong free cash flow,” CEO Bernd Montag said in a statement, though he added that the geopolitical environment remained highly volatile.
The healthcare technology group’s free cash flow increased by 54% from the same period last year, reaching 844 million euros in the third quarter that ended on June 30.
($1 = 0.8654 euros)
(Reporting by Marleen Kaesebier in Gdansk and Alexander Huebner in Munich; editing by Milla Nissi-Prussak)
Comments